Fig. 1From: Cost-effectiveness and budget impact analysis of lisdexamfetamine versus methylphenidate for patients under 18 with attention-deficit/hyperactivity disorder in IranModel structure as a decision tree model in Treeage pro healthcare 2022 for ADHD in patients under 18 years old in IranBack to article page